JP2004528311A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528311A5 JP2004528311A5 JP2002576193A JP2002576193A JP2004528311A5 JP 2004528311 A5 JP2004528311 A5 JP 2004528311A5 JP 2002576193 A JP2002576193 A JP 2002576193A JP 2002576193 A JP2002576193 A JP 2002576193A JP 2004528311 A5 JP2004528311 A5 JP 2004528311A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- optionally substituted
- formula
- independently selected
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27398801P | 2001-03-07 | 2001-03-07 | |
| US10/082,802 US6525091B2 (en) | 2001-03-07 | 2002-02-22 | Substituted diarylureas as stimulators for Fas-mediated apoptosis |
| PCT/US2002/006217 WO2002076930A2 (en) | 2001-03-07 | 2002-03-01 | Substituted diarylureas as stimulators for fas-mediated apoptosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004528311A JP2004528311A (ja) | 2004-09-16 |
| JP2004528311A5 true JP2004528311A5 (enExample) | 2006-01-05 |
Family
ID=26767870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002576193A Withdrawn JP2004528311A (ja) | 2001-03-07 | 2002-03-01 | Ｆａｓ媒介アポトーシスの刺激剤としての置換ジアリールウレア |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1366021B1 (enExample) |
| JP (1) | JP2004528311A (enExample) |
| AT (1) | ATE366720T1 (enExample) |
| AU (1) | AU2002306618B2 (enExample) |
| CA (1) | CA2434020A1 (enExample) |
| DE (1) | DE60221104T2 (enExample) |
| ES (1) | ES2286267T3 (enExample) |
| WO (1) | WO2002076930A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298311B1 (en) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| WO2004039765A1 (en) * | 2002-10-31 | 2004-05-13 | Amersham Biosciences Ab | Use of urea variants as affinity ligands |
| EP1636585B2 (en) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| US12098117B2 (en) * | 2018-12-11 | 2024-09-24 | Duke University | Compositions and methods for the treatment of cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3214468A (en) * | 1959-08-14 | 1965-10-26 | Geigy Ag J R | Bis-(trifluoromethyl)-carbanilides |
| US6093742A (en) * | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
| ATE291011T1 (de) * | 1997-12-22 | 2005-04-15 | Bayer Pharmaceuticals Corp | Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen |
| DE69830513T2 (de) * | 1997-12-22 | 2006-03-16 | Bayer Pharmaceuticals Corp., West Haven | HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN |
| AU3653099A (en) * | 1998-04-17 | 1999-11-08 | Parker Hughes Institute | Btk inhibitors and methods for their identification and use |
-
2002
- 2002-03-01 JP JP2002576193A patent/JP2004528311A/ja not_active Withdrawn
- 2002-03-01 CA CA002434020A patent/CA2434020A1/en not_active Abandoned
- 2002-03-01 WO PCT/US2002/006217 patent/WO2002076930A2/en not_active Ceased
- 2002-03-01 AU AU2002306618A patent/AU2002306618B2/en not_active Ceased
- 2002-03-01 EP EP02753691A patent/EP1366021B1/en not_active Expired - Lifetime
- 2002-03-01 DE DE60221104T patent/DE60221104T2/de not_active Expired - Fee Related
- 2002-03-01 ES ES02753691T patent/ES2286267T3/es not_active Expired - Lifetime
- 2002-03-01 AT AT02753691T patent/ATE366720T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004514663A5 (enExample) | ||
| JP2006526590A5 (enExample) | ||
| JP2020169171A5 (enExample) | ||
| JP2006523216A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2022520061A5 (enExample) | ||
| JP2008508303A5 (enExample) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2013525318A5 (enExample) | ||
| JP2008521928A5 (enExample) | ||
| JP2013056886A5 (enExample) | ||
| JP2018513150A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2006514012A5 (enExample) | ||
| JP2020512337A5 (enExample) | ||
| JP2007504235A5 (enExample) | ||
| JP2007507494A5 (enExample) | ||
| JP2009531441A5 (enExample) | ||
| JP2005508337A5 (enExample) | ||
| JP2021102643A5 (enExample) | ||
| ES2488821T3 (es) | Proceso de preparación de un compuesto antiviral | |
| US20220193106A1 (en) | Nucleobase analogue derivatives and their applications | |
| JP2006516643A5 (enExample) | ||
| JP2010505869A5 (enExample) |